Stage II Breast Cancer Withdrawn Phase 2 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00080613Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast CancerTreatment